Latest news with #Komen
Business Wire
6 days ago
- Health
- Business Wire
Susan G. Komen ® To Host Race for the Cure in New York City This September
NEW YORK--(BUSINESS WIRE)-- Susan G. Komen ®, the world's leading breast cancer organization, will convene breast cancer survivors, those living with metastatic breast cancer (MBC) and supporters at the 2025 Komen Greater New York City Race for the Cure. This impactful event unites our community and raises money for the mission of Komen. 'We look forward to bringing together the New York community this fall and uniting around our goal of creating a world where we do not lose another life to this disease.' Share Komen aims to raise $700,000 at the NYC Race for the Cure, generating critical funds that allow Komen to continue its investment in lifesaving work across the country, including promising research that will allow people to live longer lives with better outcomes. This event also funds Komen's Patient Care Center, a trusted, go-to source for timely, accurate breast health and breast cancer information, support and resources, as well as the work of Komen's Center for Public Policy to drive state and federal policies that invest in critical programs and ensure streamlined access to affordable, high-quality breast health care. WHY IT MATTERS: Breast cancer affects 1 in 8 women in the U.S. and 1 in 1,000 men in their lifetime. In 2025 alone, an estimated 316,950 women in the U.S. will be diagnosed with breast cancer and 42,170 women will die from the disease. Approximately 2,800 men will be diagnosed with breast cancer and 510 will die from it. However, some experts say one-third of breast cancer deaths in the U.S. could be prevented with universal access to modern treatments. In NEW YORK, approximately 319,750 will be diagnosed with breast cancer and 42,680 will die from the disease this year. Susan G. Komen provides direct support to New Yorkers through its Patient Care Center. In fiscal year 2025, Komen provided assistance to 1,427 of patients, including $348,400 in financial assistance to eligible people in active treatment or living with metastatic breast cancer. 'The work Komen does for people with breast cancer, survivors and those with increased risk of breast cancer is not possible without the NYC Race for the Cure and the critical money we raise from our generous supporters,' said Stacie Spitzkoff, Executive Director of Komen New York. 'We look forward to bringing together the New York community this fall and uniting around our goal of creating a world where we do not lose another life to this disease.' About Susan G. Komen ® Susan G. Komen ® is the world's leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy's life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow's cures. Visit or call 1-877 GO KOMEN. Connect with us on social at
Business Wire
07-08-2025
- Health
- Business Wire
Susan G. Komen ® To Host 2025 Race for the Cure in Detroit This September
DETROIT--(BUSINESS WIRE)-- Susan G. Komen ®, the world's leading breast cancer organization, will convene breast cancer survivors, those living with metastatic breast cancer (MBC) and supporters at the 2025 Susan G. Komen Detroit Race for the Cure. This impactful event unites our community and raises money for the mission of Komen, supporting those affected by breast cancer. This event generates critical funds that allow Komen to continue its investment in lifesaving work across the country, including promising research that will allow people to live longer lives with better outcomes. Share Komen aims to raise over $300,000 at the Detroit Race for the Cure, generating critical funds that allow Komen to continue its investment in lifesaving work across the country, including promising research that will allow people to live longer lives with better outcomes. This event also funds Komen's Patient Care Center, a trusted, go-to source for timely, accurate breast health and breast cancer information, support and resources, as well as the work of Komen's Center for Public Policy to drive state and federal policies that invest in critical programs and ensure streamlined access to affordable, high-quality breast health care. WHEN: Saturday, September 13, 2025 WHERE: William G. Milliken State Park - 1900 Atwater St, Detroit, MI 48207 WHY IT MATTERS: Breast cancer affects 1 in 8 women in the U.S. and 1 in 1,000 men in their lifetime. In 2025 alone, an estimated 316,950 women in the U.S. will be diagnosed with breast cancer and 42,170 women will die from the disease. Approximately 2,800 men will be diagnosed with breast cancer and 510 will die from it. However, some experts say one-third of breast cancer deaths in the U.S. could be prevented with universal access to modern treatments. In Michigan, approximately over 66,000 people will be diagnosed with breast cancer and over 21,500 will die from the disease this year. Susan G. Komen provides direct support to Michiganians through its Patient Care Center. In fiscal year 2025, Komen provided assistance to over 640 patients, including over $178,000 in financial assistance to eligible people in active treatment or living with metastatic breast cancer. 'The work Komen does for people with breast cancer, survivors and those with increased risk of breast cancer is not possible without the Detroit Race for the Cure and the critical money we raise from our generous supporters,' said Gretchen Awad, executive director Northwest Ohio & Detroit at Susan G. Komen. 'We look forward to bringing together the Detroit community this fall and uniting around our goal of creating a world where we do not lose another life to this disease.' This year's Komen Detroit Race for the Cure is made possible by the following sponsors: Ford Warriors in Pink, WDIV, Merck, Meijer, GAA Manufacturing, McDonald Hopkins, Oswald, Marathon, Kelly Services, Diagnostic Green, Harlan Electric, Joyology, Auto Owners Insurance, Fresh Thyme, Collingwood Water, Starbucks, Playa Bowls, Paul Mitchell The School Michigan. Bank of America is the national presenting sponsor and Lilly, Natera, and Novartis are national series sponsors for the MORE THAN PINK Walk and Race for the Cure events. About Susan G. Komen ® Susan G. Komen ® is the world's leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy's life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow's cures. Visit or call 1-877 GO KOMEN. Connect with us on social at
Business Wire
27-06-2025
- Health
- Business Wire
Susan G. Komen ® Applauds U.S. Supreme Court Decision Protecting No-cost Access to Lifesaving Breast Care
WASHINGTON--(BUSINESS WIRE)-- Susan G. Komen ®, the world's leading breast cancer organization, commends the United States Supreme Court's decision to overturn a lower court decision that threatened access to preventive breast care services, including screening mammography, risk-reducing medications for high-risk individuals, and genetic counseling and testing for some with a personal or family history of breast or related cancers. The ruling in Braidwood Management, Inc., et al v. Robert Kennedy, Jr., et al upholds the Affordable Care Act's (ACA) requirement that insurers cover services without cost-sharing that receive an A or B rating from the United States Preventive Services Taskforce (USPSTF), a decision Komen hailed as a life-saving victory for millions of Americans. 'This decision is a monumental win for public health and a critical safeguard for the 150 million Americans who depend on no-cost preventive care,' Komen stated. 'Access to screening mammograms, genetic testing, and risk-reducing medications saves lives. Today, the Court affirmed that everyone deserves a fair chance at early detection and preventive care.' Komen previously submitted an amicus curiae brief urging the Court to protect ACA provisions that have dramatically improved early detection rates and reduced late-stage breast cancer diagnoses. 'This landmark decision gives those affected by breast cancer the support and care they need in order to continue lowering mortality rates across the U.S.,' Komen continued. 'We know breast cancer is most treatable when caught early. Today's decision helps keep hope alive. We thank the Court for recognizing that preventive care is not a luxury—it is a necessity.' About Susan G. Komen ® Susan G. Komen ® is the world's leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy's life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow's cures. Visit or call 1-877 GO KOMEN. Connect with us on social at
Business Wire
23-06-2025
- Business
- Business Wire
Susan G. Komen ® Invests Nearly $11 Million to Accelerate Breakthroughs in Breast Cancer Research
DALLAS--(BUSINESS WIRE)-- Susan G. Komen ®, the world's leading breast cancer organization, announced today that it is awarding $10.8 million in new research grants that will help propel innovative science and deliver hope to those facing the disease. These research grants support 25 cutting-edge projects at 17 prestigious institutions — marking a powerful commitment to improving outcomes for people living with breast cancer today and in the future. 'We are proud to support these exceptional researchers who are pushing the boundaries of what's possible in breast cancer science,' said Paula Schneider, President and CEO of Susan G. Komen. 'Research saves lives, and now more than ever, we must invest in science that brings hope to patients — especially those facing the most aggressive forms of breast cancer.' Through this research investment, Komen is prioritizing the most pressing challenges facing patients, including metastatic breast cancer, health inequities and the need for more precise, personalized treatment strategies to improve care and outcomes for everyone impacted by breast cancer. Key Highlights of Komen's 2025 Research Investment: 54% of funding targets metastatic breast cancer — the most advanced stage of the disease, responsible for the nearly 43,000 deaths each year in the U.S. 50% focused on precision medicine to tailor treatments to each patient's unique biology. 21% invested in addressing disparities to eliminate inequities in breast cancer care and outcomes. 25 researchers funded, including 10 early-career investigators, representing the next generation of scientific leaders. 'Komen's commitment to breast cancer research comes at a pivotal time and will drive meaningful advances in our understanding of the disease and care of patients,' said Ann Partridge, M.D., M.P.H., Chief Scientific Advisor for Komen. 'By fueling science that is both innovative and inclusive, we're accelerating progress where patients need it most — while building a foundation for individualized care for all.' Komen is the largest nonprofit funder of breast cancer research outside the U.S. government, investing nearly $1.1 billion since its inception. Unlike many research institutions, Komen's work is powered entirely by the generosity of individual donors, corporate partners and community supporters. 'Investing in top scientific talent is one of the most powerful ways we can drive progress,' said Jennifer A. Pietenpol, Ph.D., Chief Scientific Advisor for Komen. 'Komen's commitment, especially to early-career researchers, cultivates a vibrant ecosystem where bold ideas and pioneering research can thrive, accelerating our path toward the cures we urgently seek.' REACHing Deeper into Research Advocacy Komen's commitment to research goes beyond funding — it includes empowering people to bring their lived experiences into the heart of science. Through its recently launched REACH (Research Education and Advocate Community Hub) initiative, Komen invites patients, survivors and co-survivors to become research advocates and help shape research. ShareforCures®, Komen's breast cancer registry, provides breast cancer patients and survivors with a new, secure and easy way to share health data to help accelerate breast cancer research. As Komen deepens its investment in research, the need for collaboration — between scientists, clinicians, advocates and patients — has never been greater. Through strategic funding, innovative patient-centric scientific programs, robust advocacy programs, education and patient support services, Susan G. Komen is leading the way so patients can benefit from scientific breakthroughs and receive the care they need to live longer, healthier lives. Recipients of Komen Grants Recipients of Career Catalyst Research Grants Chun-Kan Chen, PhD, MS, Washington University in St. Louis Miriam Jacobs, MD, Georgetown University Martina Molgora, PhD, MSc., H. Lee Moffitt Cancer Center & Research Institute, Inc. Daniel O'Neil, MD, MPH, Yale University Claire Sathe, MD, JD, Columbia University Irving Medical Center Na Zhao, PhD, Baylor College of Medicine Recipients of Career Transition Awards Charles Dai, MD, Massachusetts General Hospital Avantika Gupta, PhD, MSc, Memorial Sloan-Kettering Cancer Center Alissa Michel, MD, Columbia University Irving Medical Center Veena Padmanaban, PhD, MS, The Rockefeller University Recipients of Leadership Grants Alan Ashworth, PhD, University of California, San Francisco Tuya Pal, MD, Vanderbilt University Medical Center Rulla Tamimi, ScD, MS, Weill Medical College of Cornell University Kornelia Polyak, MD, PhD, Dana-Farber Cancer Institute Christina Curtis, PhD, MSc, Stanford University School of Medicine Jeffrey Rosen, PhD, Baylor College of Medicine Tracy Battaglia, MD, Yale University Allison Kurian, MD, MSc, Stanford University School of Medicine Nancy Lin, MD, Dana-Farber Cancer Institute Ben Ho Park, MD, PhD, Vanderbilt University Medical Center Jennifer Pietenpol, PhD, Vanderbilt University Medical Center Recipients of Opportunity Grants Filipa Lynce, MD, Dana Farber Cancer Institute Michele Cote, PhD, MPH, Indiana University Antonio Wolff, MD, Johns Hopkins University School of Medicine Recipient of Scientific Strategy and Programs Grant Adrian Lee, PhD, University of Pittsburgh To learn more about Komen's research initiatives, visit To explore how you can get involved with REACH (Research Education and Advocate Community Hub), visit About Susan G. Komen ® Susan G. Komen ® is the world's leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy's life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow's cures. Visit or call 1-877 GO KOMEN. Connect with us on social at
Business Wire
22-05-2025
- Health
- Business Wire
Millions at Risk: Komen Speaks Out Against House Reconciliation Bill
DALLAS--(BUSINESS WIRE)-- Susan G. Komen ®, the world's leading nonprofit breast cancer organization, is deeply troubled by passage of legislation by the House of Representatives which drastically cuts funding for federal health insurance programs and implements damaging reforms. The Congressional Budget Office estimates these changes, combined with the failure to renew health care tax credits, could cause nearly 14 million people to lose their insurance coverage, increasing the U.S. uninsured rate by 30%. Put simply, if enacted into law, this legislation will inflict serious harm on the breast cancer community. This health coverage is essential to ensuring timely access to breast cancer screening, diagnosis and treatment — care that might otherwise be delayed until the disease is more advanced and expensive to treat. Share Medicaid and the Affordable Care Act (ACA) Marketplaces often serve as a lifeline for many people in the breast cancer community, from those seeking screening to those in treatment and beyond. In the U.S., more than 72 million people rely on Medicaid. In fact, 1 in 10 adults with a history of cancer utilize Medicaid for insurance coverage. Millions of others rely on plans offered through the ACA Marketplaces. This health coverage is essential to ensuring timely access to breast cancer screening, diagnosis and treatment — care that might otherwise be delayed until the disease is more advanced and expensive to treat. The National Breast and Cervical Cancer Early Detection Program, a state-federal partnership which aims to increase early detection among women with low-incomes, works in conjunction with state Medicaid programs to provide treatment for those who are diagnosed with breast cancer — an effort that maximizes our nation's investment in both programs. The bill requires work reporting requirements that would restrict access to quality and affordable healthcare for millions of patients. Even if breast cancer patients qualify for exceptions from the work reporting requirements, which remains unclear, they would still be required to navigate through administrative red tape to demonstrate their qualification. Additionally, this legislation proposes eligibility checks on Medicaid enrollees every 6 months, further increasing the administrative burden for enrollees, which is the last thing a person undergoing cancer treatment should have to face. Additional policies included in the bill make several changes to ACA Marketplace plans, including codifying harmful regulations, shortening the open enrollment period, and enhancing eligibility checks, eroding coverage for the millions of Americans, including breast cancer patients and survivors. Komen urges Congress to do better for the breast cancer community and asks the Senate to reject the policies which will hurt the breast cancer patients, survivors and many other Americans when they consider the budget reconciliation bill next. Join us in this effort by contacting your U.S. Senators here. Susan G. Komen ® is the world's leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy's life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow's cures. Visit or call 1-877 GO KOMEN. Connect with us on social at
